Calidi Biotherapeutics, Inc. (CLDI)
SG&A Expense Growth
-18.57%
Fiscal year · Period ending:
CLDI SG&A Expense Growth
Latest reported-18.57%period ending
Latest reported-18.57%period ending
CLDI FY SG&A Growth (YoY) (0.00% → -18.57%)
Latest values, visible window
High-resolution chart · PNG
CLDI sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -18.5688% | |
| -19.3068% | |
| 2.1864% | |
| 153.805% | |
| 71.6235% | |
| 0% |